Cargando…

Rad50 promotes ovarian cancer progression through NF‐κB activation

Rad50 is a component of MRN (Mre11‐Rad50‐Nbs1), which participates in DNA double‐strand break repair and DNA‐damage checkpoint activation. Here, we sought to investigate the clinical and functional significance of Rad50 in high‐grade serous ovarian cancer (HGSOC). We found that Rad50 was frequently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yinuo, Wang, Shourong, Li, Peng, Li, Yingwei, Liu, Yao, Fang, Haiya, Zhang, Xiyu, Liu, Zhaojian, Kong, Beihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642684/ https://www.ncbi.nlm.nih.gov/pubmed/34734468 http://dx.doi.org/10.1111/jcmm.17017

Ejemplares similares

SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52
por: Diao, Yuchao, et al.
Publicado: (2022)

Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2
por: Wang, Shourong, et al.
Publicado: (2021)

Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12
por: Wang, Zixiang, et al.
Publicado: (2022)

Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells
por: Xu, Limei, et al.
Publicado: (2020)

MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2
por: Tian, Xiaoxue, et al.
Publicado: (2020)

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
por: Dong, Ruifen, et al.
Publicado: (2014)

CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression
por: Xu, Ying, et al.
Publicado: (2018)

Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51
por: Wang, Bingliang, et al.
Publicado: (2015)

Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer
por: Hou, Dong, et al.
Publicado: (2018)

PBK drives PARP inhibitor resistance through the TRIM37/NFκB axis in ovarian cancer
por: Ma, Hanlin, et al.
Publicado: (2022)

The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5
por: Li, Yingwei, et al.
Publicado: (2022)

MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS
por: Li, Fangfang, et al.
Publicado: (2022)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2019)

Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer
por: Wang, Shourong, et al.
Publicado: (2023)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2020)

Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1
por: Zhao, Chen, et al.
Publicado: (2021)

RAD51 is essential for spermatogenesis and male fertility in mice
por: Qin, Junchao, et al.
Publicado: (2022)

Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma
por: Song, Jianping, et al.
Publicado: (2021)

Indistinguishable Landscapes of Meiotic DNA Breaks in rad50(+) and rad50S Strains of Fission Yeast Revealed by a Novel rad50(+) Recombination Intermediate
por: Hyppa, Randy W., et al.
Publicado: (2008)

TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway
por: Qi, Gonghua, et al.
Publicado: (2021)

p53 and ANXA4/NF-κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma
por: Liu, Juanjuan, et al.
Publicado: (2020)

LINC00494 Promotes Ovarian Cancer Development and Progression by Modulating NFκB1 and FBXO32
por: Shu, Yang, et al.
Publicado: (2021)

Galectin-1 promotes tumor progression via NF-κB signaling pathway in epithelial ovarian cancer
por: Chen, Le, et al.
Publicado: (2017)

RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers
por: Alblihy, Adel, et al.
Publicado: (2020)

Annexin A4 fucosylation enhances its interaction with the NF-kB p50 and promotes tumor progression of ovarian clear cell carcinoma
por: Wang, Huimin, et al.
Publicado: (2016)

The levels of NF-κB p50 and NF-κB p65 play a role in thyroid carcinoma malignancy in vivo
por: Le, Fei, et al.
Publicado: (2018)

Interplay of Rad51 with NF-κB Pathway Stimulates Expression of HIV-1
por: Kaminski, Rafal, et al.
Publicado: (2014)

HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer
por: Dou, Zhiyuan, et al.
Publicado: (2022)

Research progress of NF-κB signaling pathway and thrombosis
por: Wang, Zilong, et al.
Publicado: (2023)

Osteoarthritis is Prevented in Rats by Verbascoside via Nuclear Factor kappa B (NF-κB) Pathway Downregulation
por: Ma, Hongbing, et al.
Publicado: (2020)

NF-κB Signaling in Ovarian Cancer
por: Harrington, Brittney S., et al.
Publicado: (2019)

PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
por: Ma, Hanlin, et al.
Publicado: (2019)

Overexpression of PRC1 indicates a poor prognosis in ovarian cancer
por: Bu, Hualei, et al.
Publicado: (2020)

Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
por: Zhang, Zaixin, et al.
Publicado: (2022)

NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
por: Uno, Masaya, et al.
Publicado: (2014)

Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB
por: Ou, Chien-Chih, et al.
Publicado: (2012)

Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation
por: Nakamura-Yanagidaira, Tomoko, et al.
Publicado: (2011)

Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
por: Chang, Lihong, et al.
Publicado: (2016)

NF‐κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin
por: Li, Shan, et al.
Publicado: (2019)

PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas
por: XIANG, LI, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hq44ppo4g3t93u7mvr21b6soud